Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

about

Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.

P2860

Q52643559-5A03E46D-6E4B-4454-8EFF-03409ECB4F5D

P2860

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

Item

http://www.wikidata.org/entity/Q41514180

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

@en

type

Item

label

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

@en

prefLabel

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

@en

P1476

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

@en

P2093

Ergang Liu

http://www.w3.org/2001/XMLSchema#string

Meng Zhang

http://www.w3.org/2001/XMLSchema#string

Yanna Cui

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis for cancer treatment decisions

A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics

How cell death shapes cancer

Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles

Structure-Based Design, Synthesis, Evaluation, and Crystallographic Studies of Conformationally Constrained Smac Mimetics as Inhibitors of the X-linked Inhibitor of Apoptosis Protein (XIAP) †

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Codelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumor

Cancer drug resistance: an evolving paradigm

Targeting multidrug resistance in cancer

P304

212-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.20892/J.ISSN.2095-3941.2017.0054

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yongzhuo Huang

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28884039

http://www.w3.org/2001/XMLSchema#string

P921

nanotechnology

multiple drug resistance

P932

5570599

http://www.w3.org/2001/XMLSchema#string

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

about

P2860

P2860

Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932